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A B S T R A C T
The aim of the study was to determine a combination of anthropometric variables that would enable better differentia-
tion between benign and malignant ovarian masses. Prospective study has been performed in a two year period in which
208 women with ovarian lesions were analyzed and correlated with histopathologic surgical findings. We examined the
relation between self-reported anthropometric and other variables (height, weight, body mass index – BMI, parity, mari-
tal status, education, age, rural versus urban residence, menopausal status) and incidence of ovarian cancer. Age, parity,
marital status and menopausal status individually showed statistical significance.
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Introduction
Ovarian cancer is the 6th most common form of ma-
lignancy in females, and the second of all genital tract
cancer, being the highest mortality rate of all genital
tract cancers. The incidence of ovarian cancer in women
is 4.3%. The most common forms of malignant ovary can-
cer are the surface epithelial-stromal tumors that ac-
count for 80–90% of all ovarian malignancies. Risk fac-
tors for the ovarian cancer are not as clear as for other
genital tumors. Some authors indicate that risk factors
for ovarian cancer are: infertility, nulliparity, low parity,
family history and nutrition (animal fat, proteins, gala-
ctosis, high calories)1,2. Some authors believe that factors
like oral contraceptives, breastfeeding, vegetarian food
and vitamins A and C 3 have protective role.
It would be very helpful to define the risk factors for
ovarian cancer, and to determine the groups of women
with higher risk of ovarian cancer. The group of women
with the higher risk, would be included into more inten-
sive screening that would give us the opportunity to dis-
cover the illness in its early stages and providing such pa-
tients an adequate treatment resulting in lower mor-
tality. It would be beneficiary to discover the means of
distinguishing the benign changes from the malignant
ones so that the unnecessary invasive procedures could
be avoided, resulting with preserved fertility and lowered
morbidity.
Materials and Methods
We studied 208 women with ovarian tumor in the pro-
spective study. All women were hospitalized at the Uni-
versity hospital »Sestre Milosrdnice« in Zagreb between
January the 1st of 2001. and 31st of December 2002. All
studied patients had a surgery due to the diagnosis of
ovarian tumorous mass. The women were classified into
the various groups according to the following factors: the
environment where they lived (rural or urban area),
marital status (married, single, divorced, widows), level
of education (primary school-low, high school-medium,
university degree-high) and the last group were the pa-
tients of reproductive age in relation to the patients in
menopause.
Weight and height were measured for all women and
body mass index (BMI) was calculated. We compared
those parameters with final results of patohystologic tu-
mor analysis, and observed in which groups ovary cancer
occurred more often. To describe numeric variables we
applied arithmetic mean, standard deviation and the me-
dian value. For description of qualitative variables we ap-
plied frequency and percentage. For the comparison of
the patients with malignant or benign changes nonpa-
rametric Mann-Whitney test for numeric variables and
c2 test for qualitative variables were applied.
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Results
208 patients with tumorous change of the ovary were
analyzed, 120 (57.7%) with benign changes, 7 (3.4%)
with borderline type and 81 (38.9%) with malignant
ovary change. Considering the low number of the pa-
tients with borderline type of the tumor we did not con-
sider that group statistically significant and therefore
have not analyzed it further.
Regarding the age of the patients, benign tumors
were found in the youngest patient group (45.4 years;
12.68 years, 46 years), the malignant change was found
in the oldest patient group (57.12 years; 13.28 years; 55
years), the difference was statistically significant (p=
0.001, Table 1). We did not found significant difference
between these groups regarding weight, height or BMI
(Table 1). (The results are expressed as arithmetic mean,
standard deviation and the median).
When considering the environmental factor we did
not find statistically significant differences between our
observed groups (Table 2).
Regarding the professional qualification there were
some differences between the groups. In patients with
high professional qualification benign tumor was found
in 19.2% (23 patients), 63.3% (76 patients) in patients
with medium professional qualification and 17.5% (21
patient) with low professional qualification. At the some
time in patients with malignant tumor of ovary 12.3%
(10 patients) had high level of professional qualification,
59.3% (48 patients) with medium professional qualifica-
tion and 28.4% (23 patients) with low professional quali-
fication.
The difference between the groups was not statisti-
cally significant (c2 test), but in low professional qualifi-
cation group the patients had the highest tendency for
malignant illness (Table 3).
Regarding the marital status within the group with
benign tumor 60.8% (73 patients) were married, 25.8%
(31 patients) were single, 4.2% (5 patients) were di-
vorced, and 9.2% (11 patients) were widows. Within the
group of patients with malignant tumor 63% (51 patient)
were married, 9.9% (8 patients) were single, 12.3% (10
patients) were divorced, and 14.8% (12 patients) were
widows. There is a significant difference between the
groups (p=0.007) (c²=12.065, df 3), and the most distinc-
tive difference was found in the prevalence of malignant
versus benign tumors between single and divorced pa-
tient groups (Table 4).
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TABLE 1
THE DIFFERENCES BETWEEN THE GROUP OF PATIENTS WITH BENIGN, BORDERLINE AND MALIGNANT TUMOR OF OVARY
IN CORRELATION TO AGE, HEIGHT, WEIGHT AND BODY MASS INDEX, EXPRESSED AS ARITHMETIC MEAN, STANDARD DEVIATION
AND MEDIAN
Benign tumors Borderline tumors Malignant tumors
Number of patients(208) 120 (57.7%) 7 (3.4%) 81 (38.9%)
Age* 45.40 12.68 46.00 53.14 11.63 56.00 57.12 13.28 55.00
Height (cm) 164.84 6.12 164.50 163.86 5.15 165.00 162.89 5.55 165.00
Weight (kg) 70.61 14.50 67.00 78.29 20.50 83.00 70.56 12.11 69.00
BMI (kg/m²) 26.02 5.29 25.19 29.09 7.34 28.06 26.67 4.75 25.78
*p – 0.001 Mann-Whitney test, comparing the groups with malignant and benign tumor, BMI – body mass index
TABLE 2
THE DIFFERENCES BETWEEN THE GROUPS OF PATIENTS
WITH BENIGN, BORDERLINE AND MALIGNANT TUMOR OF








Urban 69 (57.5%) 6 (85.7%) 50 (61.7%)
Rural 51 (42.5%) 1 (14.3%) 31 (38.3%)
TABLE 3
THE DIFFERENCES IN PREVALENCE OF BENIGN, MALIGNANT
AND BORDERLINE TUMORS ACCORDING TO LEVEL OF










High 23 (19.2%) 1 (14.3%) 10 (12.3%)
Medium 76 (63.3%) 3 (42.9%) 48 (59.3%)
Low 21 (17.5%) 3 (42.9%) 23 (28.4%)
TABLE 4
THE DIFFERENCES IN PREVALENCE OF BENIGN, MALIGNANT









Married 73 (60.8%) 5 (71.4%) 51 (63%)
Single 31 (25.8%) 2 (28.6%) 8 (9.9%)
Divorced 5 (4.2%) – 10 (12.3%)
Widow 11 (9.2%) – 12 (14.8%)
p – 0.007, (c²=12.065, df 3)
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The difference considering menopause was also sta-
tistically significant. Prevalence of benign change was
38.3% (46 patients) in women in menopause vs. 61.7%
(74 patients) in women of reproductive age. In the group
of patients with malignant tumor there were 69.1% (56
patients) patients in menopause vs. 30.9% (25 patients)
of reproductive age. The deviation regarding menopause
in patients with malignant and benign tumor was statis-
tically significant (p=0.001, c2 =18.357, df 1, Table 5).
Discussion
Ovary cancer is frequent illness with high mortality
rate. That is why it is the main object of various re-
searches. Particularly meaningful would be to distin-
guish risk factors for ovary cancer enabling determina-
tion of the risk groups that require more careful monito-
ring and more frequent controls.
Some authors questioned the influence of smoking4,
alcohol5, long-term consummation of coffee5 and the in-
fluence of war6. Other authors found higher risk in
women who worked in beauty saloons7, dry cleaning
stores8, telephone operators and telegraphists. Rodri-
guez et al.9 have found statistically significant lower
mortality rate in shorter women (152) and higher mor-
tality rate in taller women (³177 cm). As obesity in-
creases risk for some diseases10 its connection with can-
cers was also investigated. Postmenopausal weight is not
clearly connected the ovary cancer. Engeland et al.11 have
found positive correlation between height and ovary can-
cer. Woman who had high BMI in the adolescent age or
early adult age had increased risk for developing illness
comparing to woman with normal BMI. Such correlation
has not been found in elder age groups. Kuper et al.12
have not found significant difference in the incidence of
ovary cancer regarding weight, height and BMI in their
study. In premenopausal woman weight and BMI have
been connected to increased risk for cancer but without
statistical significance. The studies of Anderson et al.13
and Fairfeld et al.14 implicate that the higher BMI in
younger adult age is related to higher (increased) risk for
ovary cancer in pre and post menopauses. Women with
increased weight in adult age do not have higher inci-
dence of disease. These research gives us one more rea-
son for avoiding high weight in adolescence. Maso et al.15
have shown in their study that the weight and BMI de-
termined a year before ovary carcinoma diagnosis have
not increased the risk for developing this disease. Luka-
nova et al.16 have found reversed correlation between
BMI and cancer risk. This information implicate that in-
creased BMI can be protective factor against developing
ovary cancer. In our research we used current values of
weight and height. Comparing BMI of patients with be-
nign and malignant changes of the ovary we did not find
any statistically significant differences from which we
can conclude that BMI is not predisponant factor of be-
nign or malignant illness. These data support the results
from other studies. Considering BMI indirect measure of
fatness we can conclude that the current weight of the
patient has no meaning in predicting of benign or malig-
nant change of the ovary.
Many authors researched risk factors for ovary cancer
in urban-rural environment. Wronkowski et al.17 have
analyzed the incidence of ovary cancer in urban environ-
ment in Warsaw versus rural environment surrounding
Warsaw. They found that the Warsaw has higher inci-
dence of ovary carcinoma than the villages surrounding
Warsaw and whole Poland. Koch et al.18 have also shown
different incidence of ovary cancer in urban and rural
places but without statistical significance. Our Clinical
Hospital supplies both groups of patients, the ones from
rural and the ones from urban environments. We re-
searched weather there is any difference in the incidence
between malignant or benign changes of ovary consider-
ing the environmental factor. Our data have showed
higher incidence of malignancy in town than in rural
places but without statistical significance.
Many studies question the impact of marital status on
the incidence and survival rate on patients with ovary
cancer. Demopoulos et al19. have found that the risk of
the disease is three times higher in single woman than
married ones, but they pointed out that marital status is
in tight connection with parity. Parity directly and with
high significance has an impact to the incidence of ovary
cancer.
In prospective study authors from Norway20 have
found no significant correlation between ovary cancer
and birth age, menopause age or marital status. The only
relevant factor was parity.
In our research, regarding marital status, we found
statistically significant difference in the incidence of
ovary cancer. Single women have higher incidence of be-
nign changes on the ovaries which can be explained with
the fact that the single woman are more likely younger
and still not married. The distribution of data towards
malignant disease in divorced women group surprised
us. We assumed that the quantity of stress in lives of di-
vorced women is higher and connected with the higher
incidence of the disease.
The level of education and possible correlation with
incidence of ovary cancer was the subject of research in
many investigations. Faggiano et al.21, in their multi-
centric study, have questioned correlation between edu-
cation, socioeconomic status of patients with carcinoma
and have found higher incidence of ovary carcinoma in
patients with better socioeconomic status and higher
level of education. Shai from New York22 showed the op-
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TABLE 5
THE DIFFERENCES BETWEEN PATIENTS WITH MALIGNANT,









Yes 46 (38.3%) 4 (57.1%) 56 (69.1%)
No 74 (61.7%) 3 (42.9%) 25 (30.9%)
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posite results and found the higher incidence of ovary
carcinoma in patients with lower socioeconomic status
and lower level of professional qualification. This results
could be explained with poorer health care. Purdie et
al.23 have in large research in Australia found reversed
correlation between level of professional qualification
and ovary carcinoma.
In our research we did not find any statistical signifi-
cance in the incidence of benign and malignant changes
in comparison to high, medium and low level of profes-
sional qualification in women. Higher incidence of malig-
nant changes were found in women with low level of pro-
fessional qualification what correlates with other lite-
rature results. Increased incidence of ovary cancer in the
group with low education could be explained by irregular
controls therefore the benign changes more often stay
unrecognized. The incidence of ovary carcinoma in post-
menopausal women is significantly higher than in repro-
ductive age24 and is increasing with the age. It is predom-
inantly illness of peri and postmenopausal women25. In
our research in the group of postmenopausal women
there was higher incidence of malignancy and in the
premenopausal women there was higher incidence of be-
nign changes of the ovary. The differences were statisti-
cally significant. Such results correlate with results of
many authors.
The age of patients is in tight correlation with meno-
pausal status. We found statistically significant differ-
ences in the incidence of benign and malignant changes
regarding age. Benign changes were more common in
younger women and the incidence of malignancy was
higher in the elder age groups.
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ANTROPOLO[KI ^IMBENICI U POJAVNOSTI RAKA JAJNIKA
S A @ E T A K
Cilj rada je bio prona}i kombinaciju nekih antropolo{kih obilje`ja koja bi omogu}ila bolje razlikovanje benigne i
maligne mase na jajniku. U dvogodi{nje prospektivno istra`ivanje bilo je uklju~eno 208 `ena s promjenama na jajnicima
koje su ispitivane, a rezultati ispitivanja uspore|ivani s histopatolo{kim nalazom. Ispitivali smo me|usobni odnos ne-
kih anamnesti~ki dobivenih antropometrijskih i drugih parametara (visina, te`ina, indeks tjelesne mase-BMI, paritet,
bra~ni status, naobrazba, godine, ruralno ili urbano stani{te, menopauzalni status) i pojavnost raka jajnika. Godine,
paritet, bra~ni status i menopauzalni status promatrani pojedina~no su pokazali statisti~ki zna~ajnu razliku.
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